64 related articles for article (PubMed ID: 10374432)
1. CD 80(B7-1) expression on human tumor cell lines and its costimulatory signals for T cell proliferation and cytokine production.
Yan J; Ma B; Guo X; Sun Y; Zhang J; Zhang H
Chin Med J (Engl); 1998 Mar; 111(3):269-71. PubMed ID: 10374432
[TBL] [Abstract][Full Text] [Related]
2. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
Foreman KE; Wrone-Smith T; Krueger AE; Nickoloff BJ
Clin Immunol; 1999 Jun; 91(3):345-53. PubMed ID: 10370381
[TBL] [Abstract][Full Text] [Related]
3. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 12 and B7/CD28 interaction synergistically upregulate interleukin 10 production by human T cells.
Peng X; Kasran A; Ceuppens JL
Cytokine; 1997 Jul; 9(7):499-506. PubMed ID: 9237812
[TBL] [Abstract][Full Text] [Related]
5. CD80-transfected human breast and ovarian tumor cell lines: improved immunogenicity and induction of cytolytic CD8+ T lymphocytes.
Gückel B; Lindauer M; Rudy W; Habicht A; Siebels M; Kaul S; Bastert G; Meuer SC; Moebius U
Cytokines Mol Ther; 1995 Sep; 1(3):211-21. PubMed ID: 9384677
[TBL] [Abstract][Full Text] [Related]
6. IL-7 induces surface expression of B7/BB1 on pre-B cells and an associated increase in their costimulatory effects on T cell proliferation.
Dennig D; O'Reilly RJ
Cell Immunol; 1994 Jan; 153(1):227-38. PubMed ID: 7507002
[TBL] [Abstract][Full Text] [Related]
7. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
8. Transfection of B7-1 cDNA empowers antigen presentation of blood malignant cells for activation of anti-tumor T cells.
Ke X; Jia L; Wang J; Wang D
Chin Med J (Engl); 2003 Jan; 116(1):78-84. PubMed ID: 12667394
[TBL] [Abstract][Full Text] [Related]
9. Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway.
Ou D; Wang X; Metzger DL; Ao Z; Pozzilli P; James RF; Chen L; Warnock GL
Cell Transplant; 2006; 15(5):399-410. PubMed ID: 16970282
[TBL] [Abstract][Full Text] [Related]
10. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.
Chapoval AI; Ni J; Lau JS; Wilcox RA; Flies DB; Liu D; Dong H; Sica GL; Zhu G; Tamada K; Chen L
Nat Immunol; 2001 Mar; 2(3):269-74. PubMed ID: 11224528
[TBL] [Abstract][Full Text] [Related]
11. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
12. B7-2/CD28 costimulatory pathway in children with atopic dermatitis and its connection with immunoglobulin E, intracellular interleukin-4 and interferon-gamma production by T cells during a 1-month follow-up.
Chernyshov PV
J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):656-9. PubMed ID: 19250325
[TBL] [Abstract][Full Text] [Related]
13. Autocrine costimulation: tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7-anti-CEA diabody fusion protein.
Blanco B; Holliger P; Alvarez-Vallina L
Cancer Gene Ther; 2002 Mar; 9(3):275-81. PubMed ID: 11896444
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 requires initial CD80-mediated T-cell activation to support immune responses toward human breast and ovarian carcinoma.
Gückel B; Meyer GC; Rudy W; Batrla R; Meuer SC; Bastert G; Wallwiener D; Moebius U
Cancer Gene Ther; 1999; 6(3):228-37. PubMed ID: 10359208
[TBL] [Abstract][Full Text] [Related]
15. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy.
Li Q; Carr A; Ito F; Teitz-Tennenbaum S; Chang AE
Cancer Res; 2003 May; 63(10):2546-52. PubMed ID: 12750278
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins.
Holliger P; Manzke O; Span M; Hawkins R; Fleischmann B; Qinghua L; Wolf J; Diehl V; Cochet O; Winter G; Bohlen H
Cancer Res; 1999 Jun; 59(12):2909-16. PubMed ID: 10383154
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD3 scFv-B7.1 fusion protein expressed on the surface of HeLa cells provokes potent T-lymphocyte activation and cytotoxicity.
Yang ZM; Li EM; Lai BC; Wang YL; Si LS
Biochem Cell Biol; 2007 Apr; 85(2):196-202. PubMed ID: 17534400
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer of the CD80 costimulatory molecule into ocular melanoma cells using a novel episomal vector.
Uno T; Chen PW; Murray TG; Podack ER; Ksander BR
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2531-9. PubMed ID: 9375572
[TBL] [Abstract][Full Text] [Related]
19. Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis.
Wintterle S; Schreiner B; Mitsdoerffer M; Schneider D; Chen L; Meyermann R; Weller M; Wiendl H
Cancer Res; 2003 Nov; 63(21):7462-7. PubMed ID: 14612546
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
